Boca Biolistics is a biotechnology startup based in the United States. Established in 2009, the company's slogan "Driving Science Forward" encapsulates its mission to revolutionize the life science research field. As a unique entity, Boca Biolistics operates as a hybrid CRO, catering to the pharmaceutical, biotech, and IVD industries. The company prides itself on its ISO-certified Biobanx biospecimen inventory, ACRP and CCRA-certified clinical research services, and CLIA-certified and CAP-accredited reference laboratory services. Boca Biolistics collaborates with Pharmaceutical, IVD, and Biotech firms, aiding in the development of novel therapeutic drugs, innovative diagnostic technologies, and crucial research. The recent $25.00M Private Equity Round investment on 22 February 2023 by the Clairvest Group signifies a significant milestone for the company, manifesting investor confidence in Boca Biolistics' potential to disrupt and elevate the life science research domain.
No recent news or press coverage available for Boca Biolistics, LLC.